Raymond James & Associates’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-16,200
| Closed | -$37K | – | 4098 |
|
|
2021
Q4 | $37K | Hold |
16,200
| – | – | ﹤0.01% | 3898 |
|
|
2021
Q3 | $41K | Hold |
16,200
| – | – | ﹤0.01% | 3859 |
|
|
2021
Q2 | $46K | Hold |
16,200
| – | – | ﹤0.01% | 3844 |
|
|
2021
Q1 | $50K | Hold |
16,200
| – | – | ﹤0.01% | 3768 |
|
|
2020
Q4 | $42K | Hold |
16,200
| – | – | ﹤0.01% | 3567 |
|
|
2020
Q3 | $47K | Hold |
16,200
| – | – | ﹤0.01% | 3397 |
|
|
2020
Q2 | $56K | Hold |
16,200
| – | – | ﹤0.01% | 3313 |
|
|
2020
Q1 | $32K | Sell |
16,200
-500
| -3% | -$988 | ﹤0.01% | 3314 |
|
|
2019
Q4 | $67K | Hold |
16,700
| – | – | ﹤0.01% | 3469 |
|
|
2019
Q3 | $53K | Sell |
16,700
-146,632
| -90% | -$465K | ﹤0.01% | 3416 |
|
|
2019
Q2 | $637K | Buy |
163,332
+111,410
| +215% | +$435K | ﹤0.01% | 2494 |
|
|
2019
Q1 | $1.26M | Buy |
+51,922
| New | +$1.26M | ﹤0.01% | 2059 |
|